Press Contact
Ellen Mullally
Phone: 410-992-3124
Email: emullally@paltmed.org
JAMDA
February 23, 2021
Showing 3051 - 3060 of 7658 results
JAMDA
February 23, 2021
When “Weakness” is Something More: A Case Series of Patients Who Were Newly Diagnosed With Neurologic Conditions While Admitted to a High-Functioning Post-Acute Rehab Unit
JAMDA
February 22, 2021
Increase in Frailty in Nursing Home Survivors of Coronavirus Disease 2019: Comparison With Noninfected Residents
Institutionalized older adults have a high prevalence of frailty and disability, which may make them more vulnerable to the negative consequences of coronavirus disease 2019 (COVID-19). We investigated the impact of COVID-19 on the level of frailty, physical, and cognitive performance in nursing home resid...
JAMDA
February 22, 2021
Assessment of Coronavirus Disease 2019 Infection and Mortality Rates Among Nursing Homes With Different Proportions of Black Residents
Coronavirus disease 2019 (COVID-19) has disproportionately impacted nursing homes (NHs) with large shares of Black residents. We examined the associations between the proportion of Black residents in NHs and COVID-19 infections and deaths, accounting for structural bias (operationalized as county-level fac...
JAMDA
February 19, 2021
Appropriateness of Long-Term Acute Care Hospital Transfer: A Multicenter Study of Medicare ACO Beneficiaries
There is wide variation in long-term acute care hospital (LTACH) use nationwide, the most intensive and expensive post-acute care setting, although appropriateness of use is uncertain. Therefore, we examined the appropriateness and reasons for transfer in a high-use region, and how Medicare criteria for LT...
JAMDA
February 18, 2021
Validation of the Fracture Risk Scale Home Care (FRS-HC) Across 4 Canadian Provinces
Podcast
February 16, 2021
JAMDA On-The-Go | February 2021 | COVID-19 in Nursing Homes / Palliative Care / Driving Safety / Identifying Falls Risk
JAMDA
February 16, 2021
Renin-Angiotensin System Inhibitors Prognostic Benefit in Older Patients with Atrial Fibrillation
Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin-receptor blockers (ARB) have shown antiarrhythmic effects that are useful as part of the upstream therapy for atrial fibrillation (AF), both for primary and secondary prevention. Nevertheless, the potential prognosis value of these drugs in te...
JAMDA
February 16, 2021
Environmental Noise in New York City Long-Term Care Facilities: A Window Into the COVID-19 Pandemic
JAMDA
February 15, 2021